Post-IPO Equity - Marinus Pharmaceuticals - May 29, 2020 Funding Round Profile - Cointime

Bitcoin $79,823.37 +4.87%
Ethereum $3,215.06 +6.11%
BNB $639.34 +3.18%
Optimism $1.71 +6.99%
Arbitrum $0.64 +8.49%
Solana $211.03 +7.14%
Polygon $0.42 +9.69%
Cosmos $5.42 +15.64%
Avalanche $32.84 +13.89%

Bitcoin $79,823.37 +4.87%
Ethereum $3,215.06 +6.11%
BNB $639.34 +3.18%
Optimism $1.71 +6.99%
Arbitrum $0.64 +8.49%
Solana $211.03 +7.14%
Polygon $0.42 +9.69%
Cosmos $5.42 +15.64%
Avalanche $32.84 +13.89%

Marinus Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 46M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 14, 2017	Post-IPO Equity	$ 40.30M	Bain Capital Life Sciences	Detail
May 3, 2009	Series B	$ 20M	Canaan Partners,Domain Associates,etc.	Detail
Jan 7, 2013	Series C	$ 21M	Canaan Partners,Domain Associates,etc.	Detail
Oct 25, 2005	Series A	$ 29.40M	Canaan Partners,Domain Associates,etc.	Detail
Dec 19, 2012	Series Unknown	$ 11.43M	RMI Partners	Detail
Dec 10, 2019	Post-IPO Equity	$ 70M	Bain Capital Life Sciences	Detail
Jul 21, 2014	IPO	$ 45M		Detail